rs1555869758
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_172107.4(KCNQ2):c.994A>G(p.Arg332Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_172107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The p.R332G variant (also known as c.994A>G), located in coding exon 7 of the KCNQ2 gene, results from an A to G substitution at nucleotide position 994. The arginine at codon 332 is replaced by glycine, an amino acid with dissimilar properties. This variant has been determined to be the result of a de novo mutation in one individual with neonatal epileptic encephalopathy in our laboratory. However, the possibility of mosaicism, including in the germline of this individual's parent, could not be ruled out. This variant was not reported in population based cohorts in the following databases: NHLBI Exome Sequencing Project (ESP), 1000 Genomes Project, ExAC, and gnomAD. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
In summary, this variant is a novel missense change that has been shown to arise de novo in an affected individual. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a KCNQ2-related disease. This sequence change replaces arginine with glycine at codon 332 of the KCNQ2 protein (p.Arg332Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Family studies have indicated that this variant was not present in the parents of an individual with generalized epilepsy , which suggests that it was de novo in that affected individual (Invitae). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at